Abuse, Drug Clinical Trial
Official title:
A Double-Blind, Randomized, Crossover Study to Assess the Abuse Potential of Intranasal Cebranopadol Compared to Oxycodone and Placebo in Healthy, Nondependent Recreational Opioid Users
The purpose of this study to Assess the Abuse Potential of Intranasal Cebranopadol Compared to Oxycodone and Placebo in Healthy, Nondependent Recreational Opioid Users.
This study will be conducted to examine the intranasal abuse potential of cebranopadol compared with oxycodone HCl IR and placebo in recreational opioid users with intranasal experience, a Dose Escalation Phase (Part A) will first be conducted to determine a safe dose for evaluation in the Main Study (Part B). The Dose Selection Phase (Part A) will consist of 3 phases: Screening, Treatment and Follow-up. Subjects will participate in an outpatient medical screening visit, a 4-day treatment visit and a follow-up phone call. The Main Study (Part B) will consist of 4 phases: Screening, Qualification, Treatment and Follow-up. Subjects will participate in an outpatient screening visit, a 4-day Qualification Phase, a 30-day Treatment Phase and a follow-up phone call. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05865470 -
Age-dependent Effects of Smoked and Oral Delta-9-THC
|
Phase 1 | |
| Completed |
NCT04110535 -
Abuse Potential of Intravenous Remimazolam Compared to Midazolam and Placebo in Recreational CNS Depressant Users
|
Phase 1 | |
| Recruiting |
NCT04385082 -
Cannabis Effects as a Function of Sex (CanSex)
|
Phase 1 | |
| Recruiting |
NCT04859296 -
AnalgeSiC and appEtite-stimulating Effects of caNnabigerol and THC (ASCENT)
|
Phase 1 | |
| Recruiting |
NCT04451863 -
Analgesic and Subjective Effects of Terpenes
|
Phase 1 | |
| Completed |
NCT03757559 -
A Trial to Evaluate the Abuse Potential of 3 Doses of GRT6005 in Adult Non-dependent Recreational Opioid Users
|
Phase 1 | |
| Completed |
NCT03679949 -
Effects of Cannabis on Prescription Drug Abuse Liability and Analgesia
|
Phase 1 |